U.S. Logistics Stock News

NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

JOYY (JOYY) Q2 Results And Outlook Put Fair Value Back In Focus

JOYY (NasdaqGS:JOYY) stock is back in focus after the company paired its second quarter 2026 results with fresh third quarter revenue guidance between US$602 million and US$622 million, along with a higher full year non GAAP operating income growth outlook. JOYY shares have been relatively steady in the short term, with the stock near US$74.85 and a 90 day share price return of 13.53%. The 1 year total shareholder return of 50.82% and 3 year total shareholder return of 148.29% point to...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Stock Slips As Growth Outlook Cools Despite Strong Margins

Intuit stock slipped 3.3% today, giving back some of its recent gains, even as the company posted what looks like one of the cleanest profit stories in large cap software. Full year revenue landed at US$21.4b and diluted earnings per share from continuing operations reached US$16.54 on a trailing basis, with net margin at 21.3%. The market seems more focused on the softer near term revenue outlook and customer growth reset than on a year in which profit growth comfortably outpaced sales. That...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Arch Capital Group (ACGL) Pulls Back After A Strong Run But Is It Fully Valued

Arch Capital Group (ACGL) has drawn fresh attention after recent trading activity highlighted its mixed short term performance. The stock is up over the past 3 months but down over the past month. Over the past year, Arch Capital Group has delivered a 9.82% total shareholder return and a 37.40% total shareholder return over three years, while the recent 30 day share price pullback contrasts with a 90 day share price return of 11.08%. This suggests earlier momentum has cooled slightly as...
NasdaqCM:APPS
NasdaqCM:APPSSoftware

PubMatic Stock And 2 Ad Tech Picks For Shifting Youth Ad Budgets

Regulators are turning up the heat on youth-focused social media, with Meta’s proposed US$18b child-harm settlement spelling years of product tweaks and cash outflows. For investors, that kind of shock can quietly reshuffle winners and laggards as ad models and engagement habits adjust. This article unpacks what that shift might mean and walks through 3 stocks from our Digital Advertising & Youth-Audience Exposure screener that could benefit. The 3 stocks below are just a starting sample,...
NYSE:ABG
NYSE:ABGSpecialty Retail

Can Asbury Automotive Group (ABG) Stay Reasonable After An 18% Slide?

Asbury Automotive Group stock has fallen over the past year while the broader valuation checks still lean cheap, which puts the recent share performance at odds with what the value signals suggest. The stock is down 18.2% over the past year, which points to a period of weak recent returns despite earlier longer term gains. Future growth in vehicle sales and service revenue can support earnings, while pressure on used car pricing and consumer demand remains a key risk for how the market...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Salesforce Stock Puts Enterprise AI Software Leaders Back On Investor Radar

Enterprise AI is moving from buzzword to daily workflow, and the new Claudeforce tie up between Salesforce and Anthropic shows how quickly that shift can reach sales teams and CRM budgets. With Anthropic reporting an ARR run rate of $65b and Salesforce stock jumping 12% after its fiscal Q2, investors are paying attention. This article explains how that news relates to three stocks that are exposed to the same AI software story. The stocks covered below are just a sample of this enterprise AI...
NasdaqGS:UBSI
NasdaqGS:UBSIBanks

United Bankshares (UBSI), What Is Behind The Fresh Attention?

United Bankshares (UBSI) has drawn investor attention after its board declared a third quarter dividend of $0.38 per share and authorized a new share repurchase plan covering up to 6.8 million shares. At a share price of $47.45, United Bankshares has seen a 23.60% year to date share price return and a 27.38% total shareholder return over the past year, with the recent board decisions on dividends and buybacks coming after this period of stronger momentum. Scan how United Bankshares compares...
NasdaqGS:MZTI
NasdaqGS:MZTIFood

Does Marzetti (MZTI) Prioritize Margins And Buybacks Over Growth After Its Latest Earnings And Dividend?

In August 2026, The Marzetti Company reported fiscal fourth-quarter and full-year 2026 results showing slightly lower quarterly sales but higher net income and earnings per share, alongside the completion of a long-running share repurchase program and the declaration of a US$1.00 quarterly dividend. The combination of record gross profit, efficiency-driven margin gains, and retiring more than a quarter of its share count underscores how Marzetti is leaning heavily on profitability and...
NYSE:FITB
NYSE:FITBBanks

Is Fifth Third Bancorp (FITB) Undervalued Following Its Senior Notes Exchange Offer?

Fifth Third Bancorp (FITB) has launched a registered exchange offer for its senior notes, inviting holders of unregistered and Restricted Notes to swap into registered securities that carry the same economic terms but fewer transfer limitations. Fifth Third Bancorp's latest exchange offer lands after a busy period that includes a planned dual listing on NYSE Texas and ongoing investor outreach through events like the Barclays Global Financial Services Conference. The stock's 15.5% year to...
NYSE:CCS
NYSE:CCSConsumer Durables

Is Century Communities' (CCS) Uplands Expansion Hinting At A Shift Beyond Entry-Level Buyers?

Century Communities, Inc. recently held the grand opening of Uplands Phase II in Puyallup, Washington, adding five new rambler and two‑story floor plans with upgraded finishes, resort-style amenities, and pricing starting in the upper US$500,000s. The expansion of Uplands within a master-planned community near Tacoma and Seattle highlights Century Communities’ focus on amenity-rich, well-located projects that can broaden its appeal beyond purely entry-level buyers. We’ll now examine how the...
NYSE:EME
NYSE:EMEConstruction

Is EMCOR Group (EME) Undervalued After 31% Mechanical Construction Revenue Growth?

EMCOR Group (EME) drew investor attention after reporting a 31% year-over-year revenue increase in its Mechanical Construction business for Q2 2026, along with margin pressure driven mainly by a shift in project mix. That backdrop helps explain why EMCOR Group’s share price has had a mixed few months, with the stock down about 10% over the past 90 days but still delivering a 19.56% year-to-date share price return and a very large 5-year total shareholder return of 544.07%. Scan EMCOR Group’s...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

ICON (ICLR) Stock May Be 27% Below Fair Value Despite ESG Progress

ICON stock has delivered a weak share return over the past few years, yet several valuation checks currently point to the shares trading below an estimate of intrinsic value. The market price around US$168.93 contrasts with intrinsic value work that suggests the stock may be pricing in a cautious outlook. Over the past 3 years, ICON has fallen about 36.4%, which keeps recent sentiment subdued despite the company remaining a key player in clinical research services. Progress on ESG and...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave (CRWV) Stock May Be Below Fair Value As AI Deal Buzz Builds

CoreWeave stock has climbed 24.3% over the past month, yet its low overall value score and an earnings multiple screen that points to an undervalued profile send mixed signals about how much is already priced in. For investors looking at AI infrastructure exposure through CoreWeave, the recent share price strength now sits against a framework that flags both strong expectations and limited room for error. The 24.3% gain over the past month highlights how quickly sentiment has shifted, which...
NYSE:ACN
NYSE:ACNIT

3 Dividend Stocks Yielding Above 5% That Still Look Built For Long Term Income

With US 10 year Treasury yields easing as energy prices cool and debt buybacks support the long end, income investors are getting a rare window to lock in equity yields that still sit well above cash. Dividend Powerhouses that offer yields above 5%, with solid coverage and consistent growth, can help you keep income working. This article highlights three such stocks from the screener worth a closer look. The three Dividend Powerhouses below are just a starting sample. The full screen surfaced...
NYSE:AIG
NYSE:AIGInsurance

Higher Rates Could Lift AIG Stock And Other Dividend Paying Financials

Stubborn US inflation, a 3.3% core PCE reading and a “higher for longer” rate path have put income focused investors in a tight spot. Cash yields look tempting, yet stock markets still hinge on policy twists and recession risk. This article explains how that combination could affect large cap value financial stocks and presents three dividend paying companies from our screener that appear closely tied to this macro story. The three stocks covered below are just a starting sample, and the full...
NasdaqGS:BFST
NasdaqGS:BFSTBanks

Business First Bancshares (BFST) Stock Looks Cheap After Its 66% Run

Business First Bancshares has delivered a solid 65.7% return over the past three years, while the latest intrinsic value work using the Excess Returns model points to the stock trading at a meaningful discount to that estimate, even as market multiples look roughly in line with peers. A 65.7% share price gain over three years suggests the market has already recognised value in Business First Bancshares. Yet current analytics still point to room between price and intrinsic value. For bank...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA), Why Is The Latest Attention Raising Questions?

Mastercard (MA) is back in focus after appointing nearly 20-year company veteran Yasemin Bedir as president of its Eastern Europe, Middle East and Africa unit, a region that currently generates significant revenue. Mastercard shares recently approached record levels before a slight pullback, and the stock is now trading at US$598.47 after a 90 day share price return of 21.21% and a 30 day share price return of 8.48%. The 5 year total shareholder return of 76.34% points to momentum that has...
NYSE:MUX
NYSE:MUXMetals and Mining

Did McEwen’s (MUX) Leadership Shuffle Clarify or Complicate Its Long‑Term Operations Strategy?

McEwen Inc. recently announced the past retirement of Chief Operating Officer William Shaver, a mining veteran with over 55 years of experience, alongside leadership promotions focused on operations, development projects and permitting to support its long-term production ambitions. An interesting detail is that Shaver will remain on the board of McEwen Copper, helping preserve technical continuity as McEwen advances its copper portfolio and broader growth plans. Next, we will examine how...
NYSE:PPG
NYSE:PPGChemicals

PPG Industries (PPG) Leadership Reshuffle Puts Its Undervalued Narrative To The Test

PPG Industries (PPG) stock is drawing attention after the company reshaped leadership across its three global business segments, with new senior executives set to assume expanded responsibilities from September 1, 2026. Against this leadership reshuffle, PPG Industries’ recent share price performance has been mixed. The 1-day share price return is 0.68% and the 7-day share price return is 0.44%, but the 30-day share price return declined 3.42%. The 1-year total shareholder return is 4.71%,...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

CoStar Group (CSGP) Could Be 28% Below Fair Value After Profitability Turnaround

CoStar Group (CSGP) is back in focus after its latest quarterly report showed revenue of US$925 million and adjusted EBITDA of US$184 million, with profitability metrics improving despite guidance that tracked closely with peers. Despite the stronger profitability profile, CoStar Group’s share price has been under pressure, with the stock down 51.07% on a year to date basis and the 1 year total shareholder return declining 64.07%. However, a 10.18% 1 month share price return hints at...
NYSE:RGA
NYSE:RGAInsurance

Reinsurance Group Of America (RGA) Draws Undervalued Attention, Is The Stock Still Cheap?

Reinsurance Group of America (RGA) is back in focus after recent coverage highlighted its P/E and P/B ratios relative to industry peers, along with an earnings outlook that has encouraged renewed investor interest. At a share price of US$246.55, Reinsurance Group of America has seen momentum build, with a 90 day share price return of 20.53% and a year to date share price return of 21.19%. The 1 year total shareholder return of 29.31% and 5 year total shareholder return of 132.03% suggest...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Pulse Biosciences (PLSE), Why Is Attention Building Around It?

Pulse Biosciences (PLSE) has drawn attention after recent share price strength, with the stock up over the past month and over the past three months. Investors are assessing what the latest moves imply for future expectations. For context, the current share price of Pulse Biosciences is US$48.10. The stock has logged a 46.69% 30 day share price return and a 94.42% 90 day share price return, while the 1 year total shareholder return of 203.47% and a very large 3 year total shareholder return...
NasdaqGS:WDC
NasdaqGS:WDCTech

Dell Stock And Two AI Infrastructure Names Powering Data Center Demand

Central banks in Europe are still talking about further rate moves as they watch energy markets, which keeps attention on hard assets that make AI possible. While software headlines ebb and flow, the physical AI infrastructure theme links directly to power, cooling and connectivity that data centers rely on. This article looks at three AI infrastructure stocks from our screener that illustrate how this theme is playing out. The three stocks below are just a sample from this AI infrastructure...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics (TGTX) Is Up 6.5% After Lifting 2026 Revenue Guidance on BRIUMVI Momentum

TG Therapeutics recently raised its 2026 revenue guidance to about US$950 million, citing strong momentum from BRIUMVI, which delivered US$227.7 million in Q2 2026 sales. This shift highlights how a single high-performing therapy can rapidly reshape the company’s revenue outlook and heighten investor focus on execution and durability of BRIUMVI demand. Next, we’ll examine how the higher 2026 revenue guidance driven by BRIUMVI’s performance may influence TG Therapeutics’ broader investment...